Blister pack with dollars instead of pills From 2011-2019, large drug companies had areturn on investment capital of 17.3 percent, compared tothe average ROIC across all other industries of 11.5percent. (Photo: Shutterstock)

Pharma has been countering the call for government-mandatedprice restrictions by arguing that lowerindustry revenues would stymie development of needed drugs.

A group of researchers at the West Health Policy Center andJohns Hopkins Bloomberg School of Public Health say that's a lot ofhooey–claiming they have the data to back that up.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Katie Kuehner-Hebert

Katie Kuehner-Hebert is a freelance writer based in Running Springs, Calif. She has more than three decades of journalism experience, with particular expertise in employee benefits and other human resource topics.